Evidence map›Paper›PMID 17923525›Full record

ArticleInfection and immunity2007

Haemophilus ducreyi partially activates human myeloid dendritic cells.

Keith E Banks, Tricia L Humphreys, Wei Li, Barry P Katz, David S Wilkes, Stanley M Spinola

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 27 citations in OpenAlex.

  1. Molecular pathogenesis ofMicrobiology and molecular biology reviews : MMBR · 2025
    Review
  2. Article
  3. Infections caused byClinical microbiology reviews · 2024
    Review
  4. Article
  5. Interactions of the Skin PathogenFrontiers in immunology · 2020
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Host-pathogen interplay of Haemophilus ducreyi.Current opinion in infectious diseases · 2010
    Review
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

Keith E BanksDepartment of Medicine, Center for Immunobiology, Indiana University, School of Medicine, Indianapolis, IN 46202, USA.
Tricia L Humphreys
Wei Li
Barry P Katz
David S Wilkes
Stanley M Spinola
Bipar · FR

Funding

ZOSUQUIDAR TRIHYDROCHLORIDE DURING CONVENTIONAL INDUCTION AND POST-REMISSIONM01RR000750 · NCRR · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI RODRIGUEZ, HENRY · 1985 to 2008
$25.5M
VIRAL DETERMINANTS OF HSV DISEASE IN MICEU19AI031494 · NIAID · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI KATZ, BARRY P. · 1995 to 2009
$13.6M
PATHOGENESIS OF HAEMOPHILUS DUCREYI INFECTIONSR01AI027863 · NIAID · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI SPINOLA, STANLEY M. · 1995 to 2013
$3.8M
Training in STIs and infections of global health significanceT32AI007637 · NIAID · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI WOOLS-KALOUSTIAN, KARA KAY · 2001 to 2020
$3.4M
Human Immune Response to Haemophilus Ducreyi InfectionR01AI059384 · NIAID · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI SPINOLA, STANLEY M. · 2007 to 2011
$1.8M
PATHOGENESIS OF HAEMOPHILUS DUCREYI INFECTIONSR29AI027863 · NIAID · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI SPINOLA, STANLEY M · 1990 to 1994
–
VARIABILITY IN HERPES SIMPLEX VIRUS GLYCOPROTEINS AND INFECTIVITYU01AI031494 · NIAID · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI SEIFERT, H. STEVEN · 1991 to 1994
–
NCRR NIH HHS M01 RR000750NCRR NIH HHS M01RR00750NIAID NIH HHS AI059384NIAID NIH HHS AI27863NIAID NIH HHS AI31494NIAID NIH HHS R01 AI027863NIAID NIH HHS R01 AI059384NIAID NIH HHS T32 AI007637NIAID NIH HHS U19 AI031494
6 · The paper itself

Abstract

Dendritic cells (DC) orchestrate innate and adaptive immune responses to bacteria. How Haemophilus ducreyi, which causes genital ulcers and regional lymphadenitis, interacts with DC is unknown. H. ducreyi evades uptake by polymorphonuclear leukocyte and macrophage-like cell lines by secreting LspA1 and LspA2. Many H. ducreyi strains express cytolethal distending toxin (CDT), and recombinant CDT causes apoptosis of DC in vitro. Here, we examined interactions between DC and H. ducreyi 35000HP, which produces LspA1, LspA2, and CDT. In human volunteers infected with 35000HP, the ratio of myeloid DC to plasmacytoid DC was 2.8:1 in lesions, compared to a ratio of 1:1 in peripheral blood. Using myeloid DC derived from monocytes as surrogates for lesional DC, we found that DC infected with 35000HP remained as viable as uninfected DC for up to 48 h. Gentamicin protection and confocal microscopy assays demonstrated that DC ingested and killed 35000HP, but killing was incomplete at 48 h. The expression of LspA1 and LspA2 did not inhibit the uptake of H. ducreyi, despite inactivating Src kinases. Infection of DC with live 35000HP caused less cell surface marker activation than infection with heat-killed 35000HP and lipopolysaccharide (LPS) and inhibited maturation by LPS. However, infection of DC with live bacteria caused the secretion of significantly higher levels of interleukin-6 and tumor necrosis factor alpha than infection with heat-killed bacteria and LPS. The survival of H. ducreyi in DC may provide a mechanism by which the organism traffics to lymph nodes. Partial activation of DC may abrogate the establishment of a full Th1 response and an environment that promotes phagocytosis.

Indexed as

AdultBacterial ProteinsChancroidCytokinesDendritic CellsFemaleHaemophilus ducreyiHumansLectinsMaleMyeloid CellsPhagocytosissrc-Family KinasesBacterial ProteinsCytokinesLectinsLspA1 protein, Haemophilus ducreyiLspA2 protein, Haemophilus ducreyisrc-Family Kinases

Identifiers

PMID17923525
PMCPMC2168323
OpenAlexW2144967676

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.